海森药业(001367)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

001367 海森药业

交易中 04-08 09:37:27

{"stockData":{"symbol":"001367","market":"SZ","secType":"STK","nameCN":"海森药业","latestPrice":25.82,"timestamp":1775612247000,"preClose":25.82,"halted":0,"volume":708400,"delay":0,"changeRate":0,"floatShares":39799200,"shares":152000000,"eps":0.9794,"marketStatus":"交易中","change":0,"latestTime":"04-08 09:37:27","open":26.07,"high":26.21,"low":25.42,"amount":18329000,"amplitude":0.0306,"askPrice":25.84,"askSize":11,"bidPrice":25.82,"bidSize":2,"shortable":0,"etf":0,"ttmEps":0.9794,"tradingStatus":2,"nextMarketStatus":{"tag":"午间休市","tradingStatus":4,"beginTime":1775619000000},"marketStatusCode":2,"adr":0,"adjPreClose":25.82,"symbolType":"stock","openAndCloseTimeList":[[1775611800000,1775619000000],[1775624400000,1775631600000]],"highLimit":28.4,"lowLimit":23.24,"ibTradeSell":false,"ibTradeBuySell":false,"totalEquity":152351200,"isCdr":false,"pbRate":2.63,"roa":"--","peRate":26.363079,"roe":"9.6%","epsLYR":0.91,"committee":0.389474,"marketValue":3934000000,"turnoverRate":0.0178,"status":2,"floatMarketCap":1028000000},"requestUrl":"/m/hq/s/001367","defaultTab":"news","newsList":[{"id":"2625939370","title":"海森药业（001367）披露2025年度网上业绩说明会安排，4月7日股价下跌0.81%","url":"https://stock-news.laohu8.com/highlight/detail?id=2625939370","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2625939370?lang=zh_cn&edition=full","pubTime":"2026-04-07 17:36","pubTimestamp":1775554577,"startTime":"0","endTime":"0","summary":"截至2026年4月7日收盘，海森药业报收于25.82元，较前一交易日下跌0.81%，最新总市值为39.34亿元。该股当日开盘26.27元，最高26.98元，最低25.71元，成交额达1.85亿元，换手率为17.89%。近日，海森药业发布《关于举行2025年度网上业绩说明会的公告》。公司自即日起至2026年4月9日12:00前公开征集投资者问题。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026040700024511.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["001367","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2624249775","title":"海森药业：截至2026年3月31日，公司股东总户数约为1.4万户","url":"https://stock-news.laohu8.com/highlight/detail?id=2624249775","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2624249775?lang=zh_cn&edition=full","pubTime":"2026-04-02 11:36","pubTimestamp":1775100972,"startTime":"0","endTime":"0","summary":"证券之星消息，海森药业(001367)04月01日在投资者关系平台上答复投资者关心的问题。投资者提问：请问截至2026年3月 31日公司的股东总数是多少？谢谢海森药业回复：尊敬的投资者，您好！根据中登公司最新下发的股东名册，截至2026年3月31日，公司股东总户数约为1.4万户。谢谢您的关注和支持！以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026040200015200.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","001367"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2623352022","title":"股市必读：海森药业（001367）登3月27日交易所龙虎榜","url":"https://stock-news.laohu8.com/highlight/detail?id=2623352022","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2623352022?lang=zh_cn&edition=full","pubTime":"2026-03-30 01:45","pubTimestamp":1774806315,"startTime":"0","endTime":"0","summary":"截至2026年3月27日收盘，海森药业报收于25.18元，上涨4.39%，换手率44.5%，成交量17.71万手，成交额4.49亿元。当日关注点来自交易信息汇总：3月27日主力资金净流入2830.03万元，游资资金同步净流入1771.18万元。来自龙虎榜上榜：海森药业因日换手率达20%进入沪深交易所龙虎榜，为近5个交易日内首次上榜。龙虎榜上榜沪深交易所2026年3月27日公布的交易公开信息显示，海森药业因日换手率达到20%的前5只证券登上龙虎榜。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026033000000381.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["001367","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2622444398","title":"3月27日海森药业（001367）龙虎榜数据：机构净买入1412.45万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2622444398","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2622444398?lang=zh_cn&edition=full","pubTime":"2026-03-27 17:16","pubTimestamp":1774603009,"startTime":"0","endTime":"0","summary":"证券之星消息，沪深交易所2026年3月27日公布的交易公开信息显示，海森药业因日换手率达到20%的前5只证券登上龙虎榜。此次是近5个交易日内第1次上榜。截至2026年3月27日收盘，海森药业报收于25.18元，上涨4.39%，换手率44.5%，成交量17.71万手，成交额4.49亿元。从龙虎榜公布的当日买卖数据来看，机构合计净买入1412.45万元。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026032700035958.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","001367"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2622894202","title":"海森药业（001367）2025年年报简析：营收净利润同比双双增长","url":"https://stock-news.laohu8.com/highlight/detail?id=2622894202","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2622894202?lang=zh_cn&edition=full","pubTime":"2026-03-27 06:07","pubTimestamp":1774562875,"startTime":"0","endTime":"0","summary":"据证券之星公开数据整理，近期海森药业发布2025年年报。根据财报显示，海森药业营收净利润同比双双增长。截至本报告期末，公司营业总收入5.32亿元，同比上升12.88%，归母净利润1.36亿元，同比上升10.87%。按单季度数据看，第四季度营业总收入1.73亿元，同比上升14.48%，第四季度归母净利润4767.0万元，同比上升33.88%。去年的净利率为25.53%，算上全部成本后，公司产品或服务的附加值高。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026032700008415.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["001367"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2622881420","title":"异动快报：海森药业（001367）3月26日9点35分触及涨停板","url":"https://stock-news.laohu8.com/highlight/detail?id=2622881420","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2622881420?lang=zh_cn&edition=full","pubTime":"2026-03-26 09:40","pubTimestamp":1774489242,"startTime":"0","endTime":"0","summary":"证券之星3月26日盘中消息，9点35分海森药业（001367）触及涨停板。其所属行业化学制药目前上涨。领涨股为海森药业。该股为化学原料药，医药概念热股，当日化学原料药概念上涨1.21%，医药概念上涨0.94%。3月25日的资金流向数据方面，主力资金净流出31.02万元，占总成交额0.99%，游资资金净流入27.07万元，占总成交额0.86%，散户资金净流入3.95万元，占总成交额0.13%。近5日资金流向一览见下表：海森药业主要指标及行业内排名如下：以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026032600011772.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","001367"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2622074375","title":"海森药业：拟续聘立信会计师事务所为2026年度审计机构","url":"https://stock-news.laohu8.com/highlight/detail?id=2622074375","media":"证券日报 ","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2622074375?lang=zh_cn&edition=full","pubTime":"2026-03-25 21:26","pubTimestamp":1774445160,"startTime":"0","endTime":"0","summary":"证券日报网讯 3月25日，海森药业发布公告称，公司拟续聘立信会计师事务所（特殊普通合伙）为2026年度审计机构，聘期为一年。本次续聘尚需提交公司2025年年度股东会审议。（文章来源：证券日报）\n\n\n海量资讯、精准解读，尽在新浪财经APP","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"sina","url":"https://finance.sina.com.cn/stock/relnews/cn/2026-03-25/doc-inhsfmms3428154.shtml","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.art_tit_h1{#titleStyle#}a{#lv2TextColor#}.art_time, .art_cite{#sourceStyle#;} .art_cite{margin-left: 3px;}","selectors":".module-article, article","filters":"header, .voice2, .tags, #norm_qrcode_link_auto, .unfold-box, .action","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/relnews/cn/2026-03-25/doc-inhsfmms3428154.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["BK0239","001367"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2622107364","title":"海森药业(001367.SZ)发布2025年度业绩，归母净利润1.36亿元，增长10.87%","url":"https://stock-news.laohu8.com/highlight/detail?id=2622107364","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2622107364?lang=zh_cn&edition=full","pubTime":"2026-03-25 20:00","pubTimestamp":1774440016,"startTime":"0","endTime":"0","summary":"智通财经APP讯，海森药业(001367.SZ)发布2025年年度报告，该公司营业收入为5.32亿元，同比增长12.88%。归属于上市公司股东的净利润为1.36亿元，同比增长10.87%。归属于上市公司股东的扣除非经常性损益的净利润为1.28亿元，同比增长9.79%。基本每股收益为0.91元。此外，拟向全体股东每10股派发现金红利1.16元(含税)。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1418948.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["001367"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2621059918","title":"海森药业：截至2026年3月20日，公司股东总户数约为1万户","url":"https://stock-news.laohu8.com/highlight/detail?id=2621059918","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2621059918?lang=zh_cn&edition=full","pubTime":"2026-03-24 15:05","pubTimestamp":1774335930,"startTime":"0","endTime":"0","summary":"证券之星消息，海森药业(001367)03月23日在投资者关系平台上答复投资者关心的问题。投资者提问：请问截止3月20日公司股东人数是多少？谢谢！海森药业回复：尊敬的投资者，您好！截至2026年3月20日，公司股东总户数约为1万户。谢谢您的关注和支持！以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026032400019715.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","001367"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2618970503","title":"海森药业：截至2026年3月10日，公司股东总户数约为1万户","url":"https://stock-news.laohu8.com/highlight/detail?id=2618970503","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2618970503?lang=zh_cn&edition=full","pubTime":"2026-03-12 08:43","pubTimestamp":1773276188,"startTime":"0","endTime":"0","summary":"证券之星消息，海森药业(001367)03月11日在投资者关系平台上答复投资者关心的问题。投资者提问：尊敬的董秘 新年好 衷心感谢你们不厌其烦回答投资者的提问。请问贵公司2026年3月10日A股股东人数是多少？谢谢海森药业回复：尊敬的投资者，您好！截至2026年3月10日，公司股东总户数约为1万户。谢谢您的关注和支持！以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026031200006298.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["001367","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2616392555","title":"海森药业：截至2026年2月27日，公司股东总户数约为1万户","url":"https://stock-news.laohu8.com/highlight/detail?id=2616392555","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2616392555?lang=zh_cn&edition=full","pubTime":"2026-03-03 11:46","pubTimestamp":1772509593,"startTime":"0","endTime":"0","summary":"证券之星消息，海森药业(001367)03月02日在投资者关系平台上答复投资者关心的问题。投资者提问：尊敬的董秘 新年好 衷心感谢你们不厌其烦回答投资者的提问。请问贵公司2026年2月27日A股股东人数是多少？谢谢海森药业回复：尊敬的投资者，您好！截至2026年2月27日，公司股东总户数约为1万户。谢谢您的关注和支持！以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026030300017692.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","001367"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2614016792","title":"海森药业(001367)2月13日股东户数0.95万户，较上期减少5%","url":"https://stock-news.laohu8.com/highlight/detail?id=2614016792","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2614016792?lang=zh_cn&edition=full","pubTime":"2026-02-26 17:16","pubTimestamp":1772097381,"startTime":"0","endTime":"0","summary":"证券之星消息，近日海森药业披露，截至2026年2月13日公司股东户数为9500.0户，较2月10日减少500.0户，减幅为5.0%。在化学制药行业个股中，海森药业股东户数低于行业平均水平，截至2月13日，化学制药行业平均股东户数为3.43万户。从股价来看，2026年2月10日至2026年2月13日，海森药业区间跌幅为2.14%，在此期间股东户数减少500.0户，减幅为5.0%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026022600026027.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","001367"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2610914947","title":"海森药业：截至2026年2月10日，公司股东总户数约为1万户","url":"https://stock-news.laohu8.com/highlight/detail?id=2610914947","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2610914947?lang=zh_cn&edition=full","pubTime":"2026-02-12 15:06","pubTimestamp":1770879982,"startTime":"0","endTime":"0","summary":"证券之星消息，海森药业(001367)02月12日在投资者关系平台上答复投资者关心的问题。投资者提问：尊敬的董秘 新年好 衷心感谢你们不厌其烦回答投资者的提问。请问贵公司2026年2月10日A股股东人数是多少？谢谢海森药业回复：尊敬的投资者，您好！截至2026年2月10日，公司股东总户数约为1万户。谢谢您的关注和支持！以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026021200018928.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["001367","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2608840395","title":"海森药业：截至2026年1月31日，公司股东总户数约为1万户","url":"https://stock-news.laohu8.com/highlight/detail?id=2608840395","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2608840395?lang=zh_cn&edition=full","pubTime":"2026-02-03 15:18","pubTimestamp":1770103102,"startTime":"0","endTime":"0","summary":"证券之星消息，海森药业(001367)02月02日在投资者关系平台上答复投资者关心的问题。投资者提问：请问1月31日公司股东人数是多少？谢谢！海森药业回复：尊敬的投资者，您好！截至2026年1月31日，公司股东总户数约为1万户。谢谢您的关注和支持！以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026020300020230.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","001367"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2605466582","title":"海森药业：截至2026年1月10日股东户数约1.04万户","url":"https://stock-news.laohu8.com/highlight/detail?id=2605466582","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2605466582?lang=zh_cn&edition=full","pubTime":"2026-01-22 16:30","pubTimestamp":1769070638,"startTime":"0","endTime":"0","summary":"证券之星消息，海森药业(001367)01月22日在投资者关系平台上答复投资者关心的问题。投资者提问：请问1月10日公司股东人数是多少？谢谢！海森药业回复：尊敬的投资者，您好！截至2026年1月10日，公司股东总户数约为1.04万户。谢谢您的关注和支持！以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026012200024742.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["001367","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2603266741","title":"海森药业：截至2026年1月10日股东户数约1.04万户","url":"https://stock-news.laohu8.com/highlight/detail?id=2603266741","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2603266741?lang=zh_cn&edition=full","pubTime":"2026-01-14 15:04","pubTimestamp":1768374260,"startTime":"0","endTime":"0","summary":"证券之星消息，海森药业(001367)01月14日在投资者关系平台上答复投资者关心的问题。投资者提问：请问截至2026年1月10日，公司股东数是多少？海森药业回复：尊敬的投资者，您好！截至2026年1月10日，公司股东总户数约为1.04万户。谢谢您的关注和支持！以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026011400019896.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","001367"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2601856773","title":"海森药业完成2025年度持续督导培训，强化规范运作意识","url":"https://stock-news.laohu8.com/highlight/detail?id=2601856773","media":"中金财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2601856773?lang=zh_cn&edition=full","pubTime":"2026-01-06 08:36","pubTimestamp":1767659762,"startTime":"0","endTime":"0","summary":"中访网数据 中信证券股份有限公司作为浙江海森药业股份有限公司的保荐机构，于2025年12月29日通过线上线下结合的方式，对公司董事、高级管理人员、部分中层以上管理人员及控股股东、实际控制人等相关人员进行了2025年度持续督导培训。中信证券在培训报告中指出，海森药业积极配合本次督导工作，培训达到了预期效果，有助于公司相关责任主体强化合规意识，促进公司健康发展。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://sc.stock.cnfol.com/ggzixun/20260106/31917991.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"zhongjincaijing_highlight","symbols":["001367","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2601585638","title":"海森药业部分董高减持计划实施完成，财务总监提前终止减持","url":"https://stock-news.laohu8.com/highlight/detail?id=2601585638","media":"中金财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2601585638?lang=zh_cn&edition=full","pubTime":"2026-01-06 08:10","pubTimestamp":1767658249,"startTime":"0","endTime":"0","summary":"中访网数据 浙江海森药业股份有限公司于近日披露了部分董事、高级管理人员股份减持计划的最新进展。与此同时，公司财务总监潘爱娟决定提前终止其减持计划，其在减持期内仅减持3,000股，剩余未减持的21,420股股份将不再根据原计划进行减持。此次减持计划的实施不会导致公司控制权发生变更，也不会对公司治理结构及持续经营产生重大影响。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://sc.stock.cnfol.com/ggzixun/20260106/31916909.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"zhongjincaijing_highlight","symbols":["BK0239","001367"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2601353886","title":"海森药业：12月31日高管楼岩军减持股份合计2.55万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2601353886","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2601353886?lang=zh_cn&edition=full","pubTime":"2026-01-05 20:02","pubTimestamp":1767614526,"startTime":"0","endTime":"0","summary":"证券之星消息，根据1月5日市场公开信息、上市公司公告及交易所披露数据整理，海森药业最新董监高及相关人员股份变动情况：2025年12月31日公司副总经理楼岩军共减持公司股份2.55万股，占公司总股本为0.0168%。变动期间公司股价上涨0.0%，12月31日当日收盘报21.95元。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026010500035228.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["001367","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2600391060","title":"每周股票复盘：海森药业（001367）高管连续减持股份","url":"https://stock-news.laohu8.com/highlight/detail?id=2600391060","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2600391060?lang=zh_cn&edition=full","pubTime":"2026-01-03 03:33","pubTimestamp":1767382390,"startTime":"0","endTime":"0","summary":"截至2025年12月31日收盘，海森药业报收于21.95元，较上周的22.03元下跌0.36%。本周，海森药业12月29日盘中最高价报22.1元。12月31日盘中最低价报21.79元。海森药业当前最新总市值33.44亿元，在化学制药板块市值排名126/150，在两市A股市值排名4332/5181。本周关注点股本股东变化：2025年12月30日公司董事代亚、董秘胡康康共减持3.44万股，占总股本0.0226%。股本股东变化：12月26日董秘胡康康、高管潘爱娟减持1.32万股，占总股本0.0087%。当日股价下跌0.72%，收盘价为22.03元。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026010300002256.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["001367","BK0239"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"ret":0,"serverTime":1775612249309,"stockEarnings":[{"period":"1week","weight":0.0145},{"period":"1month","weight":0.1202},{"period":"3month","weight":0.1553},{"period":"6month","weight":0.102},{"period":"1year","weight":0.4696},{"period":"ytd","weight":0.1763}],"compareEarnings":[{"period":"1week","weight":-0.0004},{"period":"1month","weight":-0.0567},{"period":"3month","weight":-0.0479},{"period":"6month","weight":-0.0111},{"period":"1year","weight":0.2563},{"period":"ytd","weight":-0.0198}],"compareStock":{"symbol":"000001.SH","name":"上证指数"},"companyName":"浙江海森药业股份有限公司","boardCode":"AI0027","boardName":"医药制造业","stockholders":"14000人(较上一季度增加40.00%)","perCapita":"2842股","listingDate":"2023-04-10","address":"浙江省金华市东阳市六石街道香潭村","registeredCapital":"15235万元","survey":"　　浙江海森药业股份有限公司的主营业务是化学药品原料药及中间体研发、生产和销售。公司的主要产品是化学药品原料药、中间体。公司海外销售的比重较大，主要产品已通过国家GMP认证、部分产品通过美国FDA现场检查、墨西哥COFEPRIS现场检查、韩国MFDS认证；并获得欧洲CEP证书。","listedPrice":44.48},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.40.0","shortVersion":"4.40.0","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"海森药业(001367)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供海森药业(001367)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"海森药业,001367,海森药业股票,海森药业股票老虎,海森药业股票老虎国际,海森药业行情,海森药业股票行情,海森药业股价,海森药业股市,海森药业股票价格,海森药业股票交易,海森药业股票购买,海森药业股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"海森药业(001367)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供海森药业(001367)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}